Home

 

 

Latest Discussions

Member Spotlight

Latest Specialty News

  • A team of international researchers has learned that dose escalation of hydroxyurea treatment for children in Uganda with sickle cell anemia is more effective and has similar side effects than a lower fixed dose of the same drug. The study, known as NOHARM MTD, focused on children in Uganda, but the results could impact use of hydroxyurea worldwide, including the United States and Europe. The findings are being published in the June 25 issue of the New England Journal of Medicine.
  • Community is who we are, not where we are. The 44th Annual Conference & Exhibit is not cancelled; rather, it will be available virtually and will include everything you've come to love and expect from an APHON conference. Attendees can get CNE, view posters, talk with speakers and exhibitors, network with their peers, attend symposia and more! We've put together a list of Frequently Asked Questions for your reference. If you have a question that is not covered in this document, please send it to info@aphon.org . Please watch conference.aphon.org and your inboxes for updates on our plans for the Annual Conference. Our goal is to have this information available by mid-July.
  • Time Out Tuesday

    Part of the self-care series Take time out each Tuesday for tips and tricks to taking care of yourself during tough times! Each week APHON will release a 5-15 minute video focusing on how to take care of yourself: mind, body & spirit. Each Tuesday, videos will be shared in the Self-Care and Resiliency Community , Instagram , the website and more .

Facebook Feed

Twitter Feed

APHON Events


Log in to see this information

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.